Trial of existing antibiotic for treating Staphylococcus aureus bacteremia begins
IMAGE: Scanning electron micrograph of a human neutrophil ingesting MRSA (yellow). Credit: NIAID A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun. The trial will enroll 200 adults hospitalized with complicated S. aureus infection at approximately 20 trial sites around the United …